Karl Chalabala Stock Analyst Profile - UBS Research Coverage - Stocknear

Karl Chalabala

Stock Analyst at UBS

(2.97)
# 2997
Out of 5,506 analysts
9
Total ratings
Success rate
Average return

4 Stocks

Name Action PT Current % Upside Ratings Updated
FOLD Amicus Therapeutics
Maintains: Strong Buy
21 22
8.2 168.29% 6 May 2, 2025
SCCO Southern Copper
Maintains: Sell
47 50
128.28 -61.76% 1 Feb 23, 2023
GPOR Gulfport Energy
Maintains: Buy
21 18
185.76 -90.31% 1 Aug 14, 2017
CRK Comstock Resources
Maintains: Buy
14 12
21.45 -44.06% 1 Aug 14, 2017